<SEC-DOCUMENT>0002038013-24-000005.txt : 20240927
<SEC-HEADER>0002038013-24-000005.hdr.sgml : 20240927
<ACCEPTANCE-DATETIME>20240927155403
ACCESSION NUMBER:		0002038013-24-000005
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240927

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Onconetix, Inc.
		CENTRAL INDEX KEY:			0001782107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93586
		FILM NUMBER:		241334728

	BUSINESS ADDRESS:	
		STREET 1:		201 E. FIFTH STREET
		STREET 2:		SUITE 1900
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45202
		BUSINESS PHONE:		513-620-4101

	MAIL ADDRESS:	
		STREET 1:		201 E. FIFTH STREET
		STREET 2:		SUITE 1900
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Water Biotech, Inc.
		DATE OF NAME CHANGE:	20230424

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Water Vaccines Inc.
		DATE OF NAME CHANGE:	20190710

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scablis AG
		CENTRAL INDEX KEY:			0002038013
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		KLUENENFELDSTRASSE 22
		CITY:			BIRSFELDEN
		STATE:			V8
		ZIP:			4127
		BUSINESS PHONE:		41 79 249 47 80

	MAIL ADDRESS:	
		STREET 1:		KLUENENFELDSTRASSE 22
		CITY:			BIRSFELDEN
		STATE:			V8
		ZIP:			4127
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002038013</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common stock, par value $0.00001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/24/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001782107</issuerCik>
        <issuerName>Onconetix, Inc.</issuerName>
        <issuerCusip>68237Q104</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>201 E. FIFTH STREET</com:street1>
          <com:street2>SUITE 1900</com:street2>
          <com:city>CINCINNATI</com:city>
          <com:stateOrCountry>OH</com:stateOrCountry>
          <com:zipCode>45202</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Scablis AG</reportingPersonName>
      <citizenshipOrOrganization>V8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>581938.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>581938.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>581938.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>7.0</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>This percentage is calculated based on 8,296,772 common stocks issued and outstanding as of September 24, 2024 as provided by the Issuer</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Onconetix, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>201 E. FIFTH STREET, SUITE 1900, CINCINNATI, OHIO, 45202.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Scablis AG</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Kluenenfeldstrasse 22, CH-4127 Birsfelden, Switzerland</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Switzerland</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Amount beneficially owned: the 581,938 common stocks are held of record by Scablis AG, a private company of Switzerland</amountBeneficiallyOwned>
        <classPercent>7.01</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>581,938</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>581,938</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Scablis AG</reportingPersonName>
      <signatureDetails>
        <signature>Raymond Fehlbaum</signature>
        <title>Board Member</title>
        <date>09/27/2024</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
